Tag Archives: LLY

Short Sellers Grow More Selective on Major Pharma Stocks

Leave a reply

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study come back negative or a candidate not be approved. Conversely, if a drug gains FDA approval or passes a clinical trial, there can be big upside.

The White House has promised reforms in the health care sector, such as changing the bidding process for drugs and shortening the FDA approval process. It has yet to be seen how much headway they can actually make with these reforms.

Keep in mind that short sellers betting against big pharma are taking on an added risk. They have to pay out the ongoing high dividends on top of the cost of borrowing the shares.

The April 13 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.

Short interest in Pfizer Inc. (NYSE: PFE) decreased to 81.03 million shares from the previous 98.32 million. The stock was last seen trading at $37.06, within a 52-week range of $31.67 to $39.43.

The number of Merck & Co. Inc. (NYSE: MRK) shares short decreased to 22.95 million from 23.67 million in the previous period. Its shares were trading at $60.09, in a 52-week range of $52.83 to $66.41.

Teva Pharmaceutical Industries Ltd.s (NYSE: TEVA) short interest decreased to 55.84 million from the previous level of 59.40 million. Shares were trading at $17.56, in a 52-week range of $10.85 to $33.82.

Bristol-Myers Squibb Co. (NYSE: BMY) short interest increased to 14.32 million shares from the previous reading of 11.14 million. Shares were trading at $51.58, within a 52-week range of $50.66 to $70.05.

The number of shares short in AbbVie Inc. (NYSE: ABBV) increased to 15.66 million, compared to the previous 15.25 million. The stock was trading at $91.36, in a 52-week range of $64.61 to $125.86.

Eli Lilly and Co.s (NYSE: LLY) short interest decreased to 9.66 million shares from the previous 10.53 million. The stock was trading at $80.09. The 52-week range is $73.69 to $89.09.

ALSO READ: The 6 Most Shorted NYSE Stocks

Best Clean Energy Stocks To Invest In Right Now

Leave a reply

Under Armour (NYSE:UA) (NYSE:UAA), Fitbit (NYSE:FIT), and GoPro (NASDAQ:GPRO) were all terrible stocks to own over the past year. Under Armour and Fitbit were both cut in half, and GoPro plummeted nearly 40%.

At first glance, Under Armour, Fitbit, and GoPro don’t have a lot in common, since they compete in different industries. But if we look just a little closer, we’ll notice that these three hated companies actually share four key weaknesses that won’t fade away anytime soon.

Image source: Getty Images.

1. Slowing sales growth in saturated markets

When Under Armour, Fitbit, and GoPro went public, investors were dazzled by their incredible sales growth. However, that euphoria faded as their markets became saturated and their sales growth slowed.

FY 2014

Best Clean Energy Stocks To Invest In Right Now: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

  • [By WWW.THESTREET.COM]

    Cramer recalled recently investing in Eli Lilly (LLY) on hopes the company’s Alzheimer’s research would be worth billions. As time has worn on, Lilly’s obstacles to success seem to be mounting. Not knowing if or when Lilly might see success, Cramer said he sold the stock and moved on.

  • [By Ben Levisohn]

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’d use today’s weakness to buy Merck (MRK) , Eli Lilly (LLY) , Pfizer (PFE) and Allergan (AGN) , an Action Alerts PLUS holding.

  • [By Maxx Chatsko]

    Both Evenity and Tymlos are anabolic treatments, which means they encourage bone growth, rather than merely preventing bones from becoming more brittle, as prior generation osteoporosis drugs have done. While Eli Lilly (NYSE:LLY) was the first to market a drug in this class when Forteo gained marketing approval in 2002, it has faced no competitors despite achieving $1.5 billion in global sales last year, including $770 million in the United States. All of its patents expire by August 2019.

Best Clean Energy Stocks To Invest In Right Now: AVG Technologies N.V.(AVG)

Advisors’ Opinion:

  • [By Igor Novgorodtsev]

    InterActiveCorp (IACI) bought Ask.com for $1.85 billion in 2005. The new Perion will be worth only about 40% of that. After the merger, Perion will leapfrog its much larger rivals: Babylon and AVG (AVG). Finally, Perion should be able to increase its operating margins as it can spread its SG&A costs over a much larger base (Conduit EBITDA margin is 32% vs. Perion’s 23%). Perion will keep its senior management team intact: Josef Mandelbaum will remain its CEO and Yacov Kaufman its CFO. Perion has successfully orchestrated a roll-up acquisitions of privately-held Sweetpacks and Smilebox, so I have high confidence that they know how to integrate a new business.

Best Clean Energy Stocks To Invest In Right Now: American Financial Group, Inc.(AFG)

Advisors’ Opinion:

  • [By Lee Jackson]

    Aco-chief executive officer of American Financial Group Inc. (NYSE: AFG), Carl Linder, sold a total of 200,000 shares of the property and casualty insurance products provider at prices that ranged from $90.63 to $91.62. The total for the sale was set at $18 million. The shares closed Friday at $91.55, in a52-week range of $65.38 to $92.38. The consensus price target is $95.50.

Best Clean Energy Stocks To Invest In Right Now: Zion Oil & Gas Inc(ZN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Zion Oil & Gas, Inc. (NASDAQ: ZN) got a boost, shooting up 47 percent to $6.21.

    Spark Energy Inc (NASDAQ: SPKE) shares were also up, gaining 10 percent to $19.10. Guggenheim upgraded Spark Energy from Neutral to Buy.

  • [By Lisa Levin]

    In trading on Wednesday, energy shares fell by 0.76 percent. Meanwhile, top losers in the sector included Whiting Petroleum Corp (NYSE: WLL), down 6 percent, and Zion Oil & Gas, Inc. (NASDAQ: ZN) down 7 percent.

  • [By Lisa Levin]

    Shares of Zion Oil & Gas, Inc. (NASDAQ: ZN) got a boost, shooting up 20 percent to $5.07.

    Spark Energy Inc (NASDAQ: SPKE) shares were also up, gaining 12 percent to $19.40. Guggenheim upgraded Spark Energy from Neutral to Buy.

Best Clean Energy Stocks To Invest In Right Now: L Brands, Inc.(LB)

Advisors’ Opinion:

  • [By Teresa Rivas]

    L Brands (LB) ended at the bottom of the S&P 500 on Thursday, after disappointing guidance overshadowed better-than-expected earnings.

    L Brands slid $9.19, or 15.8%, to $48.94, its lowest close since 2013. By contrast, the S&P 500 gained 0.99 points, or 0.04%, today to 2363.81.

    Oppenheimers Anna Andreeva and Samantha Lanman reiterated an Outperform rating and $75 price target on the stock, but admit that the magnitude of L Brands downward forecast was disappointing, even with weak industry trends signaled by peers like Wal-Mart (WMT), Macys (M), and TJX Cos. (TJX).

    While they still are bullish, they admit that the bottom isnt clear:

    In the last 5 years, LB’s multiple averaged in high-teens given quality of brands/management, with 13-14x trough not seen since early ’13valuation could still compress assuming guidance isn’t conservative enough. Sticking with Outperform for now, albeit near-term visibility is worsening.

    L Brands is down 25% this year.

  • [By Chris Lange]

    With Christmas just around the corner and Black Friday already in the bag, holiday shopping is picking up. And this is especially true at L Brands Inc. (NYSE: LB), which recently reported its November sales.

  • [By Elizabeth Balboa]

    As tech falls, the once-forsaken shares of Gap Inc (NYSE: GPS), Macy’s Inc (NYSE: M), L Brands Inc (NYSE: LB), Costco Wholesale Corporation (NASDAQ: COST) and AT&T Inc. (NYSE: T) are surging.

  • [By WWW.THESTREET.COM]

    * The market bent yesterday but today it stabilized. (A good showing, all things being considered–but in no way decisive going forward).
    * Gold +$5/oz.
    * Crude oil +$0.50 and the rise is taking up some energy stocks.
    * The Russell returned to the spotlight.
    * Life insurance–particularly Lincoln National (LNC) (on an upgrade). Hartford Financial Services (HIG) gets a small lift.
    * Retail returned from the depths. The standouts–L Brands (LB) , Kohl’s (KSS) , Bed Bath (BBBY) , Nordstrom (JWN) and Gap (GPS) .
    * Ag equipment–after an analyst upgrade yesterday.
    * Brokerages.
    * Homebuilders catch a bid.
    * Day one of the Masters Golf Tournament.

Best Clean Energy Stocks To Invest In Right Now: TAL International Group Inc.(TAL)

Advisors’ Opinion:

  • [By Craig Jones]

    Instead of buying TAL Education Group (ADR) (NYSE: TAL), Cramer would buy Alibaba Group Holding Ltd (NYSE: BABA).

    Cramer thinks Burlington Stores Inc (NYSE: BURL) is going to have a good quarter, because Ross Stores, Inc. (NASDAQ: ROST) posted a good one, and they have similar business models.

Best Undervalued Stocks To Own For 2018

Leave a reply

Our Long Idea reports aim to identify those firms that the market has overlooked and that, when analyzed beyond standard metrics, are significantly undervalued. These hidden gems provide excellent upside potential to any portfolio, with little downside risk.

In addition to individual Long Ideas, we provide Model Portfolios that provide well-screened lists of companies based on specific criteria such as return on invested capital (ROIC) or dividend yield. In 2016, we added two new Model Portfolios, Exec Comp Aligned With ROIC and Safest Dividend Yields, to go along with our longstanding Most Attractive & Most Dangerous Stocks Model Portfolio, which has a long history of outperformance.

Below presents the Long Idea highlights of 2016 and the performance of our new Model Portfolios.

Long Idea Highlights

It pays to read our Long Idea reports. In 2016, 10 out of our 15 Long Idea stock and mutual fund picks saw positive returns and 13 stocks outperformed the market (S&P 500). All told, the Long Idea stocks averaged a 9.9% return in 2016, which was slightly more than the S&P 500’s return of nearly 9.5%, thereby outperforming as a long portfolio. Some of the top picks can be seen in Figure 1 below.

Best Undervalued Stocks To Own For 2018: Popular, Inc.(BPOP)

Advisors’ Opinion:

  • [By Peter Graham]

    Founded in 1893, mid cap Popular Inc (NASDAQ: BPOP) is the leading banking institution by both assets and deposits in Puerto Rico and ranks among the top 50 U.S. banks by assets. Popular provides retail, mortgage and commercial banking services through its principal banking subsidiary, Banco Popular de Puerto Rico, as well as auto and equipment leasing and financing, investment banking, broker-dealer and insurance services through specialized subsidiaries. In the United States, Popular has established a community-banking franchise providing a broad range of financial services and products with branches in New York, New Jersey and Florida under the name of Popular Community Bank.

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

Best Undervalued Stocks To Own For 2018: Cameco Corporation(CCJ)

Advisors’ Opinion:

  • [By Jim Robertson]

    Today, the Athabasca Basin is home to the McArthur River Uranium Mine -the worlds largest high-grade uranium deposit(accounting for 13% of world mine production) operated by mid cap uranium producer Cameco Corp (NYSE: CCJ).

  • [By Jim Robertson]

    Uranium was first discovered in the region in the 1940s with the first mine being the Rabbit Lake Mine which was discovered in 1968 by Gulf Mineral Resources and opened in 1975. The most important current mineisCameco Corps (NYSE: CCJ) McArthur River mine which isthe world’s largest high-grade uranium mine producing some 13% of global uranium production. Other important Athabasca Basin uranium mines include the Cigar Lake Mine, the Cluff Lake mine (now closed), the Key Lake mine and the McClean Lake mine plus the region continues to be an important center for uranium exploration for good reason as the following infographic illustrates:

Best Undervalued Stocks To Own For 2018: SodaStream International Ltd.(SODA)

Advisors’ Opinion:

  • [By Jeremy Bowman]

    SodaStream International(NASDAQ:SODA) blew the market away in 2016 as shares of the DIY soda-maker popped 142%, beating all but two stocks in the S&P 500.

  • [By Peter Graham]

    Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) reported Q1 2017 earnings before the market opened this morning. Revenue increased 14.3% to $115.3 million driven by growth in each of the Company’s four geographic regions, partially offset by a negative foreign currency exchange impact mainly due to the weakening of the Euro/U.S. Dollar exchange rate compared to the same period in 2016. Net income increased 141.8% to $14.7 million.

  • [By Peter Graham]

    Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) reportedQ2 2017 earnings before the market opened on Wednesday. Revenue increased 9.6% to $130.6 millionwith theincrease driven by growth in most of the Company’s geographic regions -mainly Western Europe, partially offset by a negative foreign currency exchange impact mainly due to the weakening of the Euro/U.S. Dollar exchange rate compared to the same period in 2016. Net income increased approximately 84% to $14.4 million. As of June 30, 2017, the Company had cash and bank deposits totaling $108.5 million compared to $57.3 millionas ofDecember 31, 2016. The CEO commented:

Best Undervalued Stocks To Own For 2018: INC Research Holdings, Inc.(INCR)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of LEE THOMAS H PARTNERS LP’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=LEE+THOMAS+H+PARTNERS+LP

    These are the top 5 holdings of LEE THOMAS H PARTNERS LPINC Research Holdings Inc (INCR) – 25,174,838 shares, 38.1% of the total portfolio. New PositionParty City Holdco Inc (PRTY) – 65,157,952 shares, 25.55% of the total portfolio. West Corp (WSTC) – 18,099,239 shares, 12.29% of the total portfolio. MoneyGram International Inc (MGI) – 23,604,607 shares, 11% of the total portfolio. Fogo de Chao Inc (FOGO) – 17,053,123 shares, 6.12% of the total portfo

Best Undervalued Stocks To Own For 2018: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By Chris Lange]

    Eli Lilly & Co. (NYSE: LLY) saw its shares in free fall on Wednesday, not from the usual rhetoric of politicians or even the election, for that matter, but a late-stage trial failure. As 24/7 Wall St. has said time and again, clinical trials can make or break biotech and pharma companies. In this case Eli Lilly hit new 52-week lows, not seen since 2014 and this will not be a loss that Eli Lilly will easily forget. Effectively, the company announced results from its Phase 3 solanezumab trial in people with mild dementia due to Alzheimers disease (AD).

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By WWW.THESTREET.COM]

    Cramer recalled recently investing in Eli Lilly (LLY) on hopes the company’s Alzheimer’s research would be worth billions. As time has worn on, Lilly’s obstacles to success seem to be mounting. Not knowing if or when Lilly might see success, Cramer said he sold the stock and moved on.

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

  • [By Ben Levisohn]

    Following the decision of the PTAB not to institute CHRS IPR on the 166 Humira formulation patent, we continue to anticipate that first likely launch of biosimilar adalimumab (Humira) in the US will be delayed until 2020, in line with our published forecasts and biosimilar model. We anticipate the open IPR hearings for the 135 dosing patent on Humira (filed by Boehringer and Coherus) to begin in Feb 2017 with the ruling in May. We rateAbbVie a Buy. We continue to prefer BUY rated Bristol-Myers Squibb (BMY), Eli Lilly (LLY) among the US names.

Best High Tech Stocks To Own Right Now

Leave a reply

Source: Reuters

Check Point Software Technologies (NASDAQ:CHKP) reported better-than-expected earnings for the consecutive straight quarter, primarily due to strong subscription sales and introduction of innovative security solutions for the cloud, mobile and advanced threat prevention.

It last posted its earnings for Q12017 on April 27th. The company reported EPS of $1.20 for the quarter, topping Street estimates of $1.19 by $0.01. The company had revenue of $435 million for the quarter compared to the Street estimate of $432 million. During the same quarter in the prior year, the company posted adjusted EPS of $1.06. Currently, analysts expect CHKP to generate revenue of $454 million and EPS of $1.23 in Q22017. CHKP has a 12-month low of $74.34 and a 12-month high of $106.38 (CMP $105). The firm’s market cap is $17.55 billion.

Best High Tech Stocks To Own Right Now: Mitsubishi UFJ Financial Group Inc(MTU)

Advisors’ Opinion:

  • [By Jim Jubak, Senior Markets Editor, MoneyShow.com]

    The one currency that is running against the weak dollar tide is the Japanese yen. The yen initially climbed on the Fed’s no taper decision—rising to 97.75 on the news—but then fell all the way back to 99 yen to the dollar and finished yesterday at 99.42. (Remember that since the yen is quoted in yen to the dollar, a higher number is a sign of a weak yen and a smaller number means the yen is getting stronger.) The thinking seems to be that the recent Japanese trade deficit will push the Bank of Japan to further weaken the yen, in order to boost Japanese exports. I continue to think that the yen will finish 2013 at weaker levels than current trading, and that leads me to continue to hold positions in Japanese stocks such as Toyota Motor (TM) and Mitsubishi UFJ Financial Group (MTU). Both stocks are members of my Jubaks Picks portfolio.

Best High Tech Stocks To Own Right Now: (SIOLF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    China Life (NYSE:LFC) holds a 44 percent stake in China Guangfa Bank and a 30 percent stake in Sino-Ocean Group (OTCPK:SIOLF). Foresea owns large stakes in Gree Electric Appliances and China Vanke. If they are forced to sell their stakes, the Chinese stock market could see a sudden downturn.

Best High Tech Stocks To Own Right Now: Eli Lilly and Company(LLY)

Advisors’ Opinion:

  • [By David Zeiler]

    Pharma stocks shot up in the wake of Donald Trump’s victory. Eli Lilly and Co. (NYSE: LLY) and Merck & Co. (NYSE: MRK) both rose about 6%, while Pfizer Inc. (NYSE: PFE) jumped 7%.

  • [By WWW.THESTREET.COM]

    Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
    Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today!   Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.

  • [By WWW.THESTREET.COM]

    Cramer recalled recently investing in Eli Lilly (LLY) on hopes the company’s Alzheimer’s research would be worth billions. As time has worn on, Lilly’s obstacles to success seem to be mounting. Not knowing if or when Lilly might see success, Cramer said he sold the stock and moved on.

  • [By WWW.THESTREET.COM]

    That’s why Cramer said he’d use today’s weakness to buy Merck (MRK) , Eli Lilly (LLY) , Pfizer (PFE) and Allergan (AGN) , an Action Alerts PLUS holding.

  • [By Dimitra DeFotis]

    Shares of Eli Lilly (LLY) are down nearly 13% this morning after a late-stage Alzheimer’s drug trial failed to produce expected results.

    Biogen(BIIB), down nearly 6% today, also is working on an Alzheimer’s treatment; Merck (MRK) shareswere down 1% in recent trading.

    Lilly was testing the drug as a treatment for mild dementia due to Alzheimer’s disease.Credit Suisse analysts were hopeful the drug trial would show “a statistically significant impact on cognition.”MarketWatch reports:

    “Eli Lilly said it would not pursue approval for the drug to treat mild dementia due to Alzheimers disease and that it will ‘evaluate the impact of these results on the development plans for solanezumab and our other Alzheimers pipeline assets’ … More specifics about the solanezumab drug, expected the night of Dec. 9 during a meeting of the Clinical Trials on Alzheimers Disease (CTAD), could have repercussions for whats called the beta amyloid hypothesis in Alzheimers disease treatments, which target protein fragments that some believe are responsible for the disease …”

    On Nov. 15, J.P. Morgan analysts Chris Schott, Aditi Singhania, Dana Flanders and Christopher Neyor noted that trial success had a low probability. But they kept their$95 price target on the stock, noting the drug pipeline offers other opportunities. Their target implies upside of more than 40% from a recent price near $66. They wrote:

    “… On solanezumab … While the FDA recommends both cognitive and function endpoints for Alzheimers drug approvals, we expect the agency to review solanezumab on the totality of evidence, and we would not be surprised to see a cognitive benefit coupled with a trend in secondary functional endpoints be sufficient for approval … regardless of the solanezumab outcome, we see a diverse range of new product opportunities supporting LLY

  • [By Keith Speights]

    With this rapidly growing market, there are plenty of opportunities for investors. Zoetis (NYSE:ZTS), Merck (NYSE:MRK), and Eli Lilly (NYSE:LLY) stand out as the top animal-health companies to buy in 2017. Here’s why.

9 Must-Own Stocks That Have Paid Over a Century of Dividends

Leave a reply

Dividend stock investing is inherently a long-term enterprise. After all, companies only pay their investors dividends once a quarter and dividend yields are calculated on an annualized basis. If you own a stock for only a few months, you’re not experiencing the full dividend potential. And if you only own a few weeks, there’s a chance you don’t get paid a dividend at all.

The real power of dividend stocks comes from the power to deliver consistent returns and growing payouts over the very long term — not several years, but more like several decades. If you pick the right stocks that can maintain and growth their distributions over that kind of time horizon, you will be richly rewarded.

However, there are only a precious few companies that can pull off that kind of long-term performance and still keep their dividend payments coming.

Here are nine companies, including big names you may know and a few you don’t, that have managed to pay dividends for a century or longer.

Must-Own Stocks: General Mills (GIS) Must-Own Stocks: General Mills (GIS)investorplace.com/wp-content/uploads/2016/04/gismsn2-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/gismsn2-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/gismsn2-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/gismsn2-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/gismsn2-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/gismsn2-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/gismsn2-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/gismsn2-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/gismsn2-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/gismsn2-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/gismsn2-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/gismsn2-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Mike Mozart via Flickr (Modified)

Dividends paid since: 1898
Current yield: 3.7%

General Mills, Inc. (NYSE:GIS) is a perfect example of an established and reliable company that has made more than 100 years of dividend payments possible. GIS is a packaged foods company behind a list of megabrands that includes Cheerios, Betty Crocker, Green Giant and other kitchen pantry mainstays.

A group of loyal customers who keep buying these high-quality products means a reliable cash flow to sustain General Mills and its dividends over the long term. Sure, growth is challenged in 2017 and recent challenges have caused the stock to roll back fairly steadily. However, after a dividend increase in March, General Mills pays roughly twice the per-share dividend that it did 10 years ago, so it’s clearly committed to the idea of returning capital to shareholders.

Don’t sweat the short-term volatility in GIS. Look to the long-term track record of dividends.

Must-Own Stocks: Consolidated Edison (ED) Must-Own Stocks: Consolidated Edison (ED)investorplace.com/wp-content/uploads/2016/04/edmsn1-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/edmsn1-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/edmsn1-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/edmsn1-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/edmsn1-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/edmsn1-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/edmsn1-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/edmsn1-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/edmsn1-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/edmsn1-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/edmsn1-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/edmsn1-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Wikimedia

Dividends paid since: 1885
Current yield: 3.1%

One of the oldest electric utilities in America, Consolidated Edison, Inc. (NYSE:ED) is also one of the oldest dividend payers on Wall Street.

All utility stocks are attractive because they are very entrenched companies with reliable businesses. Steady cash flows come from a virtual monopoly on their customers in a highly regulated industry with steep barriers to new entrants.

ED stock has outperformed this year with 20% returns in 2017 thus far, compared with about 16% gains for the S&P 500.

Must-Own Stocks: Johnson Controls (JCI) Must-Own Stocks: Johnson Controls (JCI)investorplace.com/wp-content/uploads/2016/08/jcimsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/08/jcimsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/08/jcimsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/08/jcimsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/08/jcimsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/08/jcimsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/08/jcimsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/08/jcimsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/08/jcimsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Herzi Pinki via Wikimedia (Modified)

Dividends paid since: 1887
Current yield: 2.4 percent

Johnson Controls Inc (NYSE:JCI) is a lesser-known dividend stock that has deep American roots. Starting as a company that provided “building controls” and HVAC products, Johnson has evolved much over the years to now encompass everything from energy efficiency to refrigeration technology to high-tech components for automobiles.

A waning U.S. auto market after record sales in 2015 and 2016 has weighed on JCI stock, but the dividends have been flowing for more than a century so there’s no reason to think this company is in serious long-term trouble. Shares of Johnson Controls stock are flat on the year so far.

Must-Own Stocks: Exxon Mobil (XOM) Must-Own Stocks: Exxon Mobil (XOM)investorplace.com/wp-content/uploads/2016/04/xommsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/xommsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/xommsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/xommsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/xommsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/xommsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/xommsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/xommsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/xommsn-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/xommsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/xommsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/xommsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Mike Mozart via Flickr (Modified)

Dividends paid since: 1882
Current yield: 3.7%

One of the largest and most established companies on the planet, Exxon Mobil Corporation (NYSE:XOM) is a go-to dividend stock. Investors who know their history should remember that the energy giant finds its roots in the original Standard Oil behemoth build by John D. Rockefeller, and has paid distributions to its shareholders over more than a century despite a plethora of changes in how we drill for oil and how energy is used in the global economy.

Lately, XOM stock has been under pressure thanks to weak oil prices. In calendar 2017, Exxon is actually sitting on a modest loss vs. big gains for other stocks.

However, shares have rebounded nicely since their August lows and it appears that the worst may be over for this dividend darling.

Must-Own Stocks: Eli Lilly (LLY) Must-Own Stocks: Eli Lilly (LLY)investorplace.com/wp-content/uploads/2016/10/llymsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/10/llymsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/10/llymsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/10/llymsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/10/llymsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/10/llymsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/10/llymsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/10/llymsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/10/llymsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Paul Sableman via Flickr (Modified)

Dividends paid since: 1885
Current yield: 2.5%

Eli Lilly and Co (NYSE:LLY) is one of the most respected names in pharmaceuticals, known for big-time drugs over the years that include Prozac and Cialis. But the company refuses to rest on its laurels, researching a current crop of cures for diabetes, cancer and other medical conditions to refill its product pipeline. And the drugs that it can’t create in-house it can easily acquire, as evidenced by buyouts such as the recent $6.5 billion deal to buy ImClone Systems Inc.

It has been a choppy year for Lilly, but the stock is more or less tracking the full-year returns of the S&P 500, up about 14% compared with 16% for the broader index.

Must-Own Stocks: Stanley Black & Decker (SWK) Must-Own Stocks: Stanley Black & Decker (SWK)investorplace.com/wp-content/uploads/2016/04/swkmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/swkmsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/swkmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/swkmsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/swkmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/swkmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/swkmsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/swkmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/swkmsn-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/swkmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/swkmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/swkmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Mark Hunter via Flickr (Modified)

Dividends paid since: 1877
Current yield: 1.5%

Power tool giant Stanley Black & Decker, Inc. (NYSE:SWK) has grown and evolved over the years, but its dividends have been in place since before Edison perfected his electric light bulb and well before tools even had the potential for electric power.

After Stanley acquired Black & Decker in 2010 and most recently the Craftsman tool brand at the beginning of this year, the company has achieved pretty much a strangle hold on the power tool market. Beyond this legacy tool business, SWK has branched out into sophisticated technologies including electronic security systems and retail loss prevention devices — ensuring plenty of forward-looking revenue streams to fuel future dividends.

SWK stock has done quite well in 2017, too, with roughly 42% gains since Jan. 1.

Must-Own Stocks: Procter & Gamble (PG) Must-Own Stocks: Procter & Gamble (PG)investorplace.com/wp-content/uploads/2016/04/pgmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/pgmsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/pgmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/pgmsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/pgmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/pgmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/pgmsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/pgmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/pgmsn-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/pgmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/pgmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/pgmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Mike Mozart via Flickr (Modified)

Dividends paid since: 1891
Current yield: 3.1%

An unmatched portfolio of household brands that include Duracell batteries, Gillette shaving products and Papers diapers should put Procter & Gamble Co. (NYSE:PG) near the top of any low-risk investor’s list of bulletproof stocks. And with over 100 years of dividend payouts, P&G is also a stock to consider for reliable income.

Most attractive to dividend stock investors should be the firm’s roughly 60-year streak of annual dividend increases, that shows P&G is committed to bigger payouts over time, too, and not just holding dividends steady.

Shares have underperformed in 2017, but have still delivered a small profit with 5% returns since Jan. 1.

Must-Own Stocks: Colgate-Palmolive (CL) Must-Own Stocks: Colgate-Palmolive (CL)investorplace.com/wp-content/uploads/2016/04/clmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/clmsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/clmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/clmsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/clmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/clmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/clmsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/clmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/clmsn-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/clmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/clmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/clmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Mark Tighe via Flickr (Modified)

Dividends paid since: 1895
Current yield: 2.2%

Colgate-Palmolive Company (NYSE:CL) is another mainstay of dividend stock investors. It has an equally popular line of products from Colgate toothpaste to Palmolive detergents and Speed Stick deodorant.

And thanks to the power of this company’s brands, it will be insulated from any year-to-year volatility in the U.S. economy. After all, nobody stops cleaning the dishes or brushing their teeth even if there happens to be a modest uptick in unemployment. Reliable revenue means CL stock offers a reliable dividend as a result.

Shares are up about 11% in 2017, slightly under the 16% return for the S&P 500.

Must-Own Stocks: PPG Industries (PPG) Must-Own Stocks: PPG Industries (PPG)investorplace.com/wp-content/uploads/2016/04/ppgmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-73×40.jpg 73w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-250×137.jpg 250w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-160×88.jpg 160w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-65×36.jpg 65w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-100×55.jpg 100w,https://investorplace.com/wp-content/uploads/2016/04/ppgmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/04/ppgmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: David Brossard(Modified)

Dividends paid since: 1899
Current yield: 1.6%

Originally named Pittsburgh Plate Glass, PPG Industries, Inc. (NYSE:PPG) has branched out from windows over the last century and into a host of industrial materials including auto paint, aerospace coatings and fiberglass. A diverse array of applications for its products ensure that the business has a stable stream of sales to fuel consistent dividend payments to shareholders.

Admittedly, a yield of less than 2% at present isn’t particularly appealing. But PPG stock is up nicely with 20% gains this year, so the total return of this dividend stock makes it worth a look.

Jeff Reeves is the editor of InvestorPlace.com and the author of The Frugal Investor’s Guide to Finding Great Stocks. Write him at editor@investorplace.com or follow him on Twitter via @JeffReevesIP. As of this writing, he did not hold a position in any of the aforemen